Ferronova is an innovative medical device company, which has brought together a patented magnetic probe from the University of South Australia and iron magnetic nanoparticle technology from Victoria University of Wellington, to produce an advanced diagnostic system to improve the detection of cancer metastases.
Ferronova has research collaborations with UniSA Future Industries Institute, the University of Sydney, and the University of New South Wales.
Founded in 2016, Ferronova is backed by Uniseed, Artesian Ventures, ASX-listed investment group Powerhouse Ventures, PAN Ventures, UniSA Ventures and Wellington UniVentures. The South Australian government and Australian government have provided grant funding to develop the technology.
Ferronova has research collaborations with UniSA Future Industries Institute, the University of Sydney, and the University of New South Wales.
Founded in 2016, Ferronova is backed by Uniseed, Artesian Ventures, ASX-listed investment group Powerhouse Ventures, PAN Ventures, UniSA Ventures and Wellington UniVentures. The South Australian government and Australian government have provided grant funding to develop the technology.
Location: Australia
Employees: 11-50
Total raised: $13.71M
Founded date: 2016
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors |
| 17.12.2025 | Series A | $6M | Uniseed |
| 23.01.2023 | - | $7.71M | - |
Mentions in press and media 9
| Date | Title | Description |
| 10.02.2026 | Medical biotech Ferronova completes enrolment for gastric and oesophageal cancer image-guided surgery trial. | ADELAIDE, Australia, Feb. 10, 2026 /PRNewswire/ -- Australian company Ferronova announced today it has completed enrolment of patients for its two-year trial to progress commercialisation of FerroTrace, a novel nanoparticle image-guided sur... |
| 17.12.2025 | Aussie medtech Ferronova raises another $6 million to advance image-guided cancer surgery | ADELAIDE, Australia, Dec. 17, 2025 /PRNewswire/ -- Australian company Ferronova has raised a further $6 million to progress the commercialisation of a novel nanoparticle image-guided surgery solution seeking to improve identification of can... |
| 24.01.2023 | Australia-based biotech startup Ferronova raises USD 11 million in capital | The Australian city of Adelaide, Jan. 22, 2023 — Ferronova, an Australian biotech startup, revealed today that it has received an additional USD 11 million to advance its nanoparticle platform and help surgeons more precisely find and remov... |
| 23.01.2023 | Ferronova secures A$11 million to advance nanotech image-guided cancer therapy | ADELAIDE, Australia, Jan. 23, 2023 /PRNewswire/ -- Australian biotech company Ferronova announced today it has secured a further A$11 million to progress the company's nanoparticle platform to assist surgeons to more accurately locate and r... |
| 23.01.2023 | Ferronova Raises A$11M in Funding | Ferronova, an Adelaide, Australia-based medical technology company, raised A$11M in funding. Irish company Renew Pharmaceuticals Limited led an A$8M capital raise, with a further A$3M secured via an Australian Government Co-operative Resear... |
| 22.01.2023 | Ferronova secures A$11 million to advance nanotech image-guided cancer therapy | ADELAIDE, Australia, Jan. 22, 2023 /PRNewswire/ -- Australian biotech company Ferronova announced today it has secured a further A$11 million to progress the company's nanoparticle platform to assist surgeons to more accurately locate and r... |
| - | Ferronova | “Home | Cancer Imaging | Ferronova” |
| - | ‘No tumour will go undetected’: Ferronova lands $11 million for its cancer hunting nanotechnology | Ferronova has received $11 million in funding for its nanoparticle cancer detection technology. Adelaide biotech startup Ferronova has received $11 million in funding for its nanoparticle cancer detection technology. The round was led by Re... |
| - | Ferronova | “FerroTrace®, a novel nanoparticle technology designed to enable accurate detection of high-risk lymph nodes and early identification of metastatic spread.” |